Skip to main content
Top
Published in: Journal of Translational Medicine 1/2011

Open Access 01-12-2011 | Research

Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone

Authors: Joseph CK Leung, Loretta YY Chan, Sydney CW Tang, Man-Fai Lam, Chui-Wa Chow, Ai-Ing Lim, Kar-Neng Lai

Published in: Journal of Translational Medicine | Issue 1/2011

Login to get access

Abstract

Background

Inhibition of the renin-angiotensin-aldosterone system (RAAS) slows down the progression of chronic renal diseases (CKD) including IgA nephropathy (IgAN). Herein, we studied the pathogenetic roles of aldosterone (Aldo) in IgAN.

Methods

Human mesangial cells (HMC) was activated with polymeric IgA (pIgA) from IgAN patients and the effects on the expression of RAAS components and TGF-β synthesis examined. To study the roles of RAAS in the glomerulotubular communication, proximal tubular epithelial cells (PTEC) was cultured with conditioned medium from pIgA-activated HMC with eplerenone or PD123319, the associated apoptotic event was measured by the generation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and reactive oxygen species (ROS).

Results

Polymeric IgA up-regulated the Aldo synthesis and aldosterone synthase expression by HMC. The release of TGF-β by HMC was up-regulated synergistically by AngII and Aldo and this was inhibited by incubation of HMC with losartan plus eplerenone. Cultured PTEC express the mineralocorticoid receptor, but not synthesizing aldosterone. Apoptosis, demonstrated by cleaved PARP expression and caspase 3 activity, was induced in PTEC activated by conditioned medium prepared from HMC cultured with pIgA from IgAN patients. This apoptotic event was associated with increased generation of NADPH oxidase and ROS. Pre-incubation of PTEC with PD123319 and eplerenone achieved complete inhibition of PTEC apoptosis.

Conclusions

Our data suggest that AngII and Aldo, released by pIgA activated HMC, served as mediators for inducing apoptosis of PTEC in glomerulo-tubular communications. Crosstalk between AngII and Aldo could participate in determining the tubular pathology of IgAN.
Appendix
Available only for authorised users
Literature
1.
go back to reference D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987, 64: 709-727.PubMed D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987, 64: 709-727.PubMed
2.
go back to reference D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis. 1995, 26: 124-132. 10.1016/0272-6386(95)90165-5.CrossRefPubMed D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis. 1995, 26: 124-132. 10.1016/0272-6386(95)90165-5.CrossRefPubMed
3.
go back to reference Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN: Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int. 2005, 67: 602-612. 10.1111/j.1523-1755.2005.67116.x.CrossRefPubMed Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN: Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int. 2005, 67: 602-612. 10.1111/j.1523-1755.2005.67116.x.CrossRefPubMed
4.
go back to reference Chan LY, Leung JC, Tang SC, Choy CB, Lai KN: Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol. 2005, 16: 2306-2317. 10.1681/ASN.2004121117.CrossRefPubMed Chan LY, Leung JC, Tang SC, Choy CB, Lai KN: Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol. 2005, 16: 2306-2317. 10.1681/ASN.2004121117.CrossRefPubMed
5.
go back to reference Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi PG: Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis. 1993, 21: 593-602.CrossRefPubMed Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi PG: Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis. 1993, 21: 593-602.CrossRefPubMed
6.
go back to reference Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003, 64: 149-159. 10.1046/j.1523-1755.2003.00065.x.CrossRefPubMed Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003, 64: 149-159. 10.1046/j.1523-1755.2003.00065.x.CrossRefPubMed
7.
go back to reference Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G: ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis. 1999, 34: 626-632. 10.1016/S0272-6386(99)70385-9.CrossRefPubMed Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G: ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis. 1999, 34: 626-632. 10.1016/S0272-6386(99)70385-9.CrossRefPubMed
8.
go back to reference Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, Tsang AW, Leung JC: Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol. 2003, 14: 3127-3137. 10.1097/01.ASN.0000095639.56212.BF.CrossRefPubMed Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, Tsang AW, Leung JC: Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol. 2003, 14: 3127-3137. 10.1097/01.ASN.0000095639.56212.BF.CrossRefPubMed
9.
go back to reference Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC: Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int. 2004, 66: 1403-1416. 10.1111/j.1523-1755.2004.00874.x.CrossRefPubMed Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC: Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int. 2004, 66: 1403-1416. 10.1111/j.1523-1755.2004.00874.x.CrossRefPubMed
10.
go back to reference Nishiyama A, Abe Y: Aldosterone and renal injury. Nippon Yakurigaku Zasshi. 2004, 124: 101-109. 10.1254/fpj.124.101.CrossRefPubMed Nishiyama A, Abe Y: Aldosterone and renal injury. Nippon Yakurigaku Zasshi. 2004, 124: 101-109. 10.1254/fpj.124.101.CrossRefPubMed
11.
go back to reference Mackenzie SM, Connell J: Hypertension and the expanding role of aldosterone. Curr Hypertens Rep. 2006, 8: 255-261. 10.1007/s11906-006-0059-y.CrossRefPubMed Mackenzie SM, Connell J: Hypertension and the expanding role of aldosterone. Curr Hypertens Rep. 2006, 8: 255-261. 10.1007/s11906-006-0059-y.CrossRefPubMed
12.
go back to reference Hostetter TH, Rosenberg ME, Ibrahim HN, Juknevicius I: Aldosterone in progressive renal disease. Semin Nephrol. 2001, 21: 573-579. 10.1053/snep.2001.26797.CrossRefPubMed Hostetter TH, Rosenberg ME, Ibrahim HN, Juknevicius I: Aldosterone in progressive renal disease. Semin Nephrol. 2001, 21: 573-579. 10.1053/snep.2001.26797.CrossRefPubMed
13.
go back to reference Connell JM, Davies E: The new biology of aldosterone. J Endocrinol. 2005, 186: 1-20. 10.1677/joe.1.06017.CrossRefPubMed Connell JM, Davies E: The new biology of aldosterone. J Endocrinol. 2005, 186: 1-20. 10.1677/joe.1.06017.CrossRefPubMed
14.
15.
go back to reference Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003, 63: 1791-1800. 10.1046/j.1523-1755.2003.00929.x.CrossRefPubMed Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003, 63: 1791-1800. 10.1046/j.1523-1755.2003.00929.x.CrossRefPubMed
16.
go back to reference Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002, 283: H1802-1810.CrossRefPubMed Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002, 283: H1802-1810.CrossRefPubMed
17.
go back to reference Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ: Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension. 2006, 48: 1050-1057. 10.1161/01.HYP.0000248135.97380.76.CrossRefPubMed Luther JM, Gainer JV, Murphey LJ, Yu C, Vaughan DE, Morrow JD, Brown NJ: Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension. 2006, 48: 1050-1057. 10.1161/01.HYP.0000248135.97380.76.CrossRefPubMed
18.
go back to reference Bianchi S, Bigazzi R, Campese VM: Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis. 2005, 46: 45-51. 10.1053/j.ajkd.2005.03.007.CrossRefPubMed Bianchi S, Bigazzi R, Campese VM: Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis. 2005, 46: 45-51. 10.1053/j.ajkd.2005.03.007.CrossRefPubMed
19.
go back to reference To WY, Leung JC, Lai KN: Identification and characterization of human serum alpha2-HS glycoprotein as a jacalin-bound protein. Biochim Biophys Acta. 1995, 1249: 58-64. 10.1016/0167-4838(95)00063-Z.CrossRefPubMed To WY, Leung JC, Lai KN: Identification and characterization of human serum alpha2-HS glycoprotein as a jacalin-bound protein. Biochim Biophys Acta. 1995, 1249: 58-64. 10.1016/0167-4838(95)00063-Z.CrossRefPubMed
20.
go back to reference Lai KN, To WY, Li PK, Leung JC: Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int. 1996, 49: 839-845. 10.1038/ki.1996.116.CrossRefPubMed Lai KN, To WY, Li PK, Leung JC: Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int. 1996, 49: 839-845. 10.1038/ki.1996.116.CrossRefPubMed
21.
go back to reference Tam KY, Leung JC, Chan LY, Lam MF, Tang SC, Lai KN: In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions. Am J Physiol Renal Physiol. 2010, 299: F359-368. 10.1152/ajprenal.00664.2009.CrossRefPubMed Tam KY, Leung JC, Chan LY, Lam MF, Tang SC, Lai KN: In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions. Am J Physiol Renal Physiol. 2010, 299: F359-368. 10.1152/ajprenal.00664.2009.CrossRefPubMed
22.
go back to reference Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000, 77: S93-98.CrossRefPubMed Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000, 77: S93-98.CrossRefPubMed
23.
go back to reference Durvasula RV, Shankland SJ: The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 2006, 8: 132-138. 10.1007/s11906-006-0009-8.CrossRefPubMed Durvasula RV, Shankland SJ: The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 2006, 8: 132-138. 10.1007/s11906-006-0009-8.CrossRefPubMed
24.
go back to reference Hollenberg NK: Aldosterone in the development and progression of renal injury. Kidney Int. 2004, 66: 1-9. 10.1111/j.1523-1755.2004.00701.x.CrossRefPubMed Hollenberg NK: Aldosterone in the development and progression of renal injury. Kidney Int. 2004, 66: 1-9. 10.1111/j.1523-1755.2004.00701.x.CrossRefPubMed
25.
go back to reference Nishikawa T, Suematsu S, Saito J, Soyama A, Ito H, Kino T, Chrousos G: Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol. 2005, 96: 309-316. 10.1016/j.jsbmb.2005.03.005.CrossRefPubMed Nishikawa T, Suematsu S, Saito J, Soyama A, Ito H, Kino T, Chrousos G: Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol. 2005, 96: 309-316. 10.1016/j.jsbmb.2005.03.005.CrossRefPubMed
26.
go back to reference Lai L, Chen J, Hao CM, Lin S, Gu Y: Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochem Biophys Res Commun. 2006, 348: 70-75. 10.1016/j.bbrc.2006.07.057.CrossRefPubMed Lai L, Chen J, Hao CM, Lin S, Gu Y: Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochem Biophys Res Commun. 2006, 348: 70-75. 10.1016/j.bbrc.2006.07.057.CrossRefPubMed
27.
go back to reference Onozato ML, Tojo A, Kobayashi N, Goto A, Matsuoka H, Fujita T: Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrol Dial Transplant. 2007, 22: 1314-1322. 10.1093/ndt/gfl780.CrossRefPubMed Onozato ML, Tojo A, Kobayashi N, Goto A, Matsuoka H, Fujita T: Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrol Dial Transplant. 2007, 22: 1314-1322. 10.1093/ndt/gfl780.CrossRefPubMed
28.
go back to reference Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH: Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol. 2004, 286: F1059-1062. 10.1152/ajprenal.00202.2003.CrossRefPubMed Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH: Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol. 2004, 286: F1059-1062. 10.1152/ajprenal.00202.2003.CrossRefPubMed
29.
go back to reference Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988, 242: 583-585. 10.1126/science.2845584.CrossRefPubMed Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988, 242: 583-585. 10.1126/science.2845584.CrossRefPubMed
30.
go back to reference Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C: Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet. 1988, 2: 986-989.CrossRefPubMed Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C: Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet. 1988, 2: 986-989.CrossRefPubMed
31.
go back to reference Funder JW: Reconsidering the roles of the mineralocorticoid receptor. Hypertension. 2009, 53: 286-290.CrossRefPubMed Funder JW: Reconsidering the roles of the mineralocorticoid receptor. Hypertension. 2009, 53: 286-290.CrossRefPubMed
32.
go back to reference Fjeld CC, Birdsong WT, Goodman RH: Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci USA. 2003, 100: 9202-9207. 10.1073/pnas.1633591100.PubMedCentralCrossRefPubMed Fjeld CC, Birdsong WT, Goodman RH: Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci USA. 2003, 100: 9202-9207. 10.1073/pnas.1633591100.PubMedCentralCrossRefPubMed
33.
go back to reference Funder JW: RALES, EPHESUS and redox. J Steroid Biochem Mol Biol. 2005, 93: 121-125. 10.1016/j.jsbmb.2004.12.010.CrossRefPubMed Funder JW: RALES, EPHESUS and redox. J Steroid Biochem Mol Biol. 2005, 93: 121-125. 10.1016/j.jsbmb.2004.12.010.CrossRefPubMed
34.
go back to reference Alzamora R, Michea L, Marusic ET: Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 2000, 35: 1099-1104.CrossRefPubMed Alzamora R, Michea L, Marusic ET: Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 2000, 35: 1099-1104.CrossRefPubMed
35.
go back to reference Mihailidou AS, Loan Le TY, Mardini M, Funder JW: Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension. 2009, 54: 1306-1312. 10.1161/HYPERTENSIONAHA.109.136242.CrossRefPubMed Mihailidou AS, Loan Le TY, Mardini M, Funder JW: Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension. 2009, 54: 1306-1312. 10.1161/HYPERTENSIONAHA.109.136242.CrossRefPubMed
36.
go back to reference Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007, 87: 245-313. 10.1152/physrev.00044.2005.CrossRefPubMed Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007, 87: 245-313. 10.1152/physrev.00044.2005.CrossRefPubMed
37.
go back to reference Jiang F: NADPH oxidase in the kidney: a Janus in determining cell fate. Kidney Int. 2009, 75: 135-137. 10.1038/ki.2008.478.CrossRefPubMed Jiang F: NADPH oxidase in the kidney: a Janus in determining cell fate. Kidney Int. 2009, 75: 135-137. 10.1038/ki.2008.478.CrossRefPubMed
38.
go back to reference Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal. 2006, 8: 1597-1607. 10.1089/ars.2006.8.1597.CrossRefPubMed Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal. 2006, 8: 1597-1607. 10.1089/ars.2006.8.1597.CrossRefPubMed
39.
go back to reference Lodha S, Dani D, Mehta R, Bhaskaran M, Reddy K, Ding G, Singhal PC: Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med. 2002, 8: 830-840.PubMedCentralPubMed Lodha S, Dani D, Mehta R, Bhaskaran M, Reddy K, Ding G, Singhal PC: Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med. 2002, 8: 830-840.PubMedCentralPubMed
40.
go back to reference Susztak K, Raff AC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006, 55: 225-233. 10.2337/diabetes.55.01.06.db05-0894.CrossRefPubMed Susztak K, Raff AC, Schiffer M, Bottinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006, 55: 225-233. 10.2337/diabetes.55.01.06.db05-0894.CrossRefPubMed
41.
go back to reference Tojo A, Asaba K, Onozato ML: Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets. 2007, 11: 1011-1018. 10.1517/14728222.11.8.1011.CrossRefPubMed Tojo A, Asaba K, Onozato ML: Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets. 2007, 11: 1011-1018. 10.1517/14728222.11.8.1011.CrossRefPubMed
42.
go back to reference Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002, 61: 186-194. 10.1046/j.1523-1755.2002.00123.x.CrossRefPubMed Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002, 61: 186-194. 10.1046/j.1523-1755.2002.00123.x.CrossRefPubMed
43.
go back to reference Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK: NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal. 2002, 4: 899-914. 10.1089/152308602762197443.CrossRefPubMed Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK: NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal. 2002, 4: 899-914. 10.1089/152308602762197443.CrossRefPubMed
44.
go back to reference Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004, 43: 841-848. 10.1161/01.HYP.0000118519.66430.22.CrossRefPubMed Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004, 43: 841-848. 10.1161/01.HYP.0000118519.66430.22.CrossRefPubMed
45.
go back to reference Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T: Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation. 2001, 104: 137-139.CrossRefPubMed Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T: Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation. 2001, 104: 137-139.CrossRefPubMed
46.
go back to reference Sato A, Saruta T, Funder JW: Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection. Hypertens Res. 2006, 29: 211-216. 10.1291/hypres.29.211.CrossRefPubMed Sato A, Saruta T, Funder JW: Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection. Hypertens Res. 2006, 29: 211-216. 10.1291/hypres.29.211.CrossRefPubMed
47.
go back to reference Brennan BJ, Martin NE: Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease. J Am Pharm Assoc (2003). 2004, 44: 604-610. 10.1331/1544-3191.44.5.604.Brennan.CrossRef Brennan BJ, Martin NE: Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease. J Am Pharm Assoc (2003). 2004, 44: 604-610. 10.1331/1544-3191.44.5.604.Brennan.CrossRef
48.
go back to reference Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL: Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol. 2004, 93: 990-996. 10.1016/j.amjcard.2004.01.007.CrossRefPubMed Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL: Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol. 2004, 93: 990-996. 10.1016/j.amjcard.2004.01.007.CrossRefPubMed
49.
go back to reference Lai KN, Chan LY, Leung JC: Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int Suppl. 2005, S110-115. Lai KN, Chan LY, Leung JC: Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int Suppl. 2005, S110-115.
Metadata
Title
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone
Authors
Joseph CK Leung
Loretta YY Chan
Sydney CW Tang
Man-Fai Lam
Chui-Wa Chow
Ai-Ing Lim
Kar-Neng Lai
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2011
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-9-169

Other articles of this Issue 1/2011

Journal of Translational Medicine 1/2011 Go to the issue